Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine Development – Yahoo Finance

Moderna Inc. (NASDAQ: MRNA) announced Sunday it is receiving another $472 million financing from President Donald Trumps administration to support late-stage scientific advancement of its coronavirus va. [+1933 chars]